Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZak M. Y.-
dc.contributor.authorPasiyeshvili L. M.-
dc.contributor.authorKnysh M. Y.-
dc.identifier.citationZak M. Y. Nsaids gastropathy/dyspepsia upon chronic gastritis in anamnesis in patients with osteoarthrosis / M. Y. Zak, L. M. Pasiyeshvili, M. Y. Knysh // International Journal of Scientific and Techology Research. – 2014. – Vol. 3, Issue 12. – P. 197–199.uk_UA
dc.description.abstract122 patients with osteoarthrosis, who had verified chronic gastritis in the anamnesis (50 males and 72 females), aged from 42 to 64, were examined. Control group included 40 patients with osteoarthrosis without gastroduodenal zone pathology in the anamnesis. For arthralgia relief, patients were prescribed to intake meloxicam (average dose — 12.5±1.39 mg/day) or nimesulide (average dose — 150±14.91 mg/day). As a result of this research, it was determined that prescription of selective NSAIDs (meloxicam and nimesulide) raised the risk of NSAIDs gastropathy/dyspepsia in 2.9 times (P<0.03) in patients with chronic gastritis in the anamnesis than in patients without associated gastroduodenal zone pathology. Atrophy of gastric mucous membrane was associated with higher risks (P>0.05) of erosive gastropathy. With the purpose of gastropathy prevention upon taking NSAIDs, patients with chronic gastritis in the anamnesis are recommended to undergo gastroprotective therapy.uk_UA
dc.subjectchronic gastritisuk_UA
dc.subjectNSAIDs gastropathyuk_UA
dc.subjectNSAIDs dyspepsiauk_UA
dc.titleNsaids gastropathy / dyspepsia upon chronic gastritis in anamnesis in patients with osteoarthrosisuk_UA
Appears in Collections:Наукові праці. Кафедра загальної практики – сімейної медицини та внутрішніх хвороб

Files in This Item:
File Description SizeFormat 
Nsaids-Gastropathy.pdf256,11 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.